A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
An official statement from the department says the city has only received a limited supply of the FDA-approved Jynneos monkeypox vaccine, produced by the Danish biotechnology firm Bavarian Nordic ...
Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV. The projects will combine Bavarian Nordic’s MVA-BN technology with ...
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
To confirm the efficacy of the monkeypox vaccine, Bavarian Nordic will collect data from ... company would be able to absorb the increasing demand despite having only a single production facility.
Bavarian Nordic will submit additional data over the coming months, aiming to complete the BLA submission before the end of the first half of 2024 to support a potential FDA approval of the vaccine in ...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN® smallpox vaccine to the strategic ...
By the time the U.S. placed its orders, the vaccine’s Denmark-based manufacturer, Bavarian Nordic, was unable to satisfy demand for months, the New York Times uncovered. The U.S. didn’t ...
Bavarian Nordic launches mpox vaccine in United States Semaglutide ... for approval by Jiuyuan Gene Engineering comes amid ...
In February 2024, the Committee for Medicinal Products for Human Use (CHMP) under EMA granted accelerated assessment for the MAA for the CHIKV VLP vaccine candidate, which Bavarian Nordic plans to ...